Anti-infection


Anti-infectives are agents that eliminate or inhibit the spread of infectious organisms, encompassing antibiotics, antifungals, antivirals, and antiprotozoals.
Antibiotics are a class of antimicrobial agents specifically designed to target bacterial pathogens. They exert their effects by interfering with essential bacterial processes such as cell wall synthesis, protein synthesis, nucleic acid replication, and metabolic pathways, thereby either inhibiting bacterial growth or inducing bacterial death.
Antifungals are antimicrobial agents employed to combat fungal infections (mycoses) in humans and animals. Common antifungal classes include azoles, polyenes, echinocandins, and allylamines, which function by disrupting unique fungal structures or pathways, such as the synthesis or integrity of ergosterol-containing cell membranes and β-glucan-based cell walls, or by interfering with nucleic acid or protein synthesis.
Antivirals are compounds developed to inhibit the replication and spread of viruses within host organisms. Antivirals typically act by blocking viral entry, genome replication, protein processing, or virion assembly and release. Representative examples include nucleoside analogs, protease inhibitors, and neuraminidase inhibitors.
Antiprotozoals are drugs used to treat infections caused by protozoan parasites, including malaria, amebiasis, giardiasis, and trypanosomiasis. They act through a variety of mechanisms, including inhibition of nucleic acid synthesis, interference with mitochondrial function, and disruption of heme detoxification pathways in susceptible parasites.
-
BA1865 BeclabuvirSummary: Beclabuvir is an NS5BRNA-dependent RNA polymerase inhibitor. -
BA1866 BMS-986094Summary: BMS-986094 (INX-08189) is a potent inhibitor of hepatitis C virus. -
BA1867 DDX3-IN-1Summary: DDX3-IN-1 is a DEAD-box polypeptide 3 inhibitor. -
BA1868 MK-0608Summary: MK-0608 is a potent replication inhibitor. -
BA1869 RO-9187Summary: RO-9187 is a potent inhibitor of viral replication. -
BA1870 ABT-072Summary: ABT-072 is a potent non-nucleoside inhibitor with oral activity. -
BA1871 PF-4878691Summary: PF-4878691 (3M-852A) is an orally active agonist. -
BA1872 UprifosbuvirSummary: Uprifosbuvir is an antiviral active molecule. -
BA1873 MiravirsenSummary: Miravirsen (SPC-3649) is a potent inhibitor of miR-122 biogenesis. -
BA1874 FilibuvirSummary: Filibuvir is an orally effective, selective non-nucleoside inhibitor of the non-structural 5B protein RNA-dependent RNA polymerase (RdRp).

